Illumina Body Map 2: averaged replicates
Gene Symbol | Gene ID | Gene Info |
---|---|---|
GATA2
|
ENSG00000179348.7 | GATA binding protein 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
GATA2 | hg19_v2_chr3_-_128212016_128212051 | -0.04 | 8.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_33563821 | 5.58 |
ENST00000321505.4
ENST00000265654.5 ENST00000389726.3 |
KIAA1549L
|
KIAA1549-like |
chr12_+_121088291 | 4.57 |
ENST00000351200.2
|
CABP1
|
calcium binding protein 1 |
chr6_-_127780510 | 4.46 |
ENST00000487331.2
ENST00000483725.3 |
KIAA0408
|
KIAA0408 |
chr9_+_87286997 | 4.22 |
ENST00000395866.2
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2 |
chr1_+_160085567 | 4.17 |
ENST00000392233.3
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
chr20_+_44650348 | 4.12 |
ENST00000454036.2
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5 |
chr3_+_111718173 | 3.95 |
ENST00000494932.1
|
TAGLN3
|
transgelin 3 |
chr18_-_4455283 | 3.94 |
ENST00000315677.3
|
DLGAP1
|
discs, large (Drosophila) homolog-associated protein 1 |
chr16_-_30023615 | 3.91 |
ENST00000564979.1
ENST00000563378.1 |
DOC2A
|
double C2-like domains, alpha |
chrX_-_20074895 | 3.69 |
ENST00000543767.1
|
MAP7D2
|
MAP7 domain containing 2 |
chr12_+_79371565 | 3.57 |
ENST00000551304.1
|
SYT1
|
synaptotagmin I |
chr1_+_160085501 | 3.52 |
ENST00000361216.3
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
chr17_+_70036164 | 3.33 |
ENST00000602013.1
|
AC007461.1
|
Uncharacterized protein |
chr20_+_34802295 | 3.32 |
ENST00000432603.1
|
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
chr4_+_159131596 | 3.26 |
ENST00000512481.1
|
TMEM144
|
transmembrane protein 144 |
chr5_+_56910048 | 3.11 |
ENST00000509844.1
|
CTD-2023N9.3
|
CTD-2023N9.3 |
chr21_+_34442439 | 3.10 |
ENST00000382348.1
ENST00000333063.5 |
OLIG1
|
oligodendrocyte transcription factor 1 |
chr14_+_24540046 | 3.08 |
ENST00000397016.2
ENST00000537691.1 ENST00000560356.1 ENST00000558450.1 |
CPNE6
|
copine VI (neuronal) |
chr6_+_160327974 | 3.06 |
ENST00000252660.4
|
MAS1
|
MAS1 oncogene |
chr19_-_11591848 | 3.06 |
ENST00000359227.3
|
ELAVL3
|
ELAV like neuron-specific RNA binding protein 3 |
chr11_+_33563618 | 2.93 |
ENST00000526400.1
|
KIAA1549L
|
KIAA1549-like |
chr5_+_169780485 | 2.90 |
ENST00000377360.4
|
KCNIP1
|
Kv channel interacting protein 1 |
chr3_-_20053741 | 2.87 |
ENST00000389050.4
|
PP2D1
|
protein phosphatase 2C-like domain containing 1 |
chr11_-_18765389 | 2.86 |
ENST00000477854.1
|
PTPN5
|
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) |
chr4_+_159131630 | 2.85 |
ENST00000504569.1
ENST00000509278.1 ENST00000514558.1 ENST00000503200.1 |
TMEM144
|
transmembrane protein 144 |
chr4_-_46126093 | 2.79 |
ENST00000295452.4
|
GABRG1
|
gamma-aminobutyric acid (GABA) A receptor, gamma 1 |
chr15_-_93616340 | 2.71 |
ENST00000557420.1
ENST00000542321.2 |
RGMA
|
repulsive guidance molecule family member a |
chr2_-_209051727 | 2.57 |
ENST00000453017.1
ENST00000423952.2 |
C2orf80
|
chromosome 2 open reading frame 80 |
chr9_+_12693336 | 2.51 |
ENST00000381137.2
ENST00000388918.5 |
TYRP1
|
tyrosinase-related protein 1 |
chr7_-_38670957 | 2.50 |
ENST00000325590.5
ENST00000428293.2 |
AMPH
|
amphiphysin |
chr5_-_156772729 | 2.46 |
ENST00000312349.4
|
FNDC9
|
fibronectin type III domain containing 9 |
chr7_-_38671098 | 2.44 |
ENST00000356264.2
|
AMPH
|
amphiphysin |
chr9_-_34397800 | 2.41 |
ENST00000297623.2
|
C9orf24
|
chromosome 9 open reading frame 24 |
chr6_-_80657292 | 2.41 |
ENST00000369816.4
|
ELOVL4
|
ELOVL fatty acid elongase 4 |
chr4_-_159956333 | 2.39 |
ENST00000434826.2
|
C4orf45
|
chromosome 4 open reading frame 45 |
chr4_-_168155730 | 2.38 |
ENST00000502330.1
ENST00000357154.3 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chr4_-_168155577 | 2.38 |
ENST00000541354.1
ENST00000509854.1 ENST00000512681.1 ENST00000421836.2 ENST00000510741.1 ENST00000510403.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chr15_+_51973550 | 2.37 |
ENST00000220478.3
|
SCG3
|
secretogranin III |
chr12_+_79439461 | 2.37 |
ENST00000552624.1
|
SYT1
|
synaptotagmin I |
chr5_+_152870215 | 2.34 |
ENST00000518142.1
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1 |
chr19_+_18723660 | 2.33 |
ENST00000262817.3
|
TMEM59L
|
transmembrane protein 59-like |
chr19_+_18726786 | 2.33 |
ENST00000594709.1
|
TMEM59L
|
transmembrane protein 59-like |
chr4_-_168155700 | 2.31 |
ENST00000357545.4
ENST00000512648.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chr21_+_22370717 | 2.30 |
ENST00000284894.7
|
NCAM2
|
neural cell adhesion molecule 2 |
chr12_+_79439405 | 2.30 |
ENST00000552744.1
|
SYT1
|
synaptotagmin I |
chr1_+_190448095 | 2.27 |
ENST00000424735.1
|
RP11-547I7.2
|
RP11-547I7.2 |
chr7_+_43152212 | 2.26 |
ENST00000453890.1
|
HECW1
|
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 |
chr5_+_55033845 | 2.26 |
ENST00000353507.5
ENST00000514278.2 ENST00000505374.1 ENST00000506511.1 |
DDX4
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 |
chr12_-_21487829 | 2.24 |
ENST00000445053.1
ENST00000452078.1 ENST00000458504.1 ENST00000422327.1 ENST00000421294.1 |
SLCO1A2
|
solute carrier organic anion transporter family, member 1A2 |
chr17_-_10741762 | 2.23 |
ENST00000580256.2
|
PIRT
|
phosphoinositide-interacting regulator of transient receptor potential channels |
chr11_+_124609823 | 2.20 |
ENST00000412681.2
|
NRGN
|
neurogranin (protein kinase C substrate, RC3) |
chr4_-_176828307 | 2.17 |
ENST00000513365.1
ENST00000513667.1 ENST00000503563.1 |
GPM6A
|
glycoprotein M6A |
chr17_-_50237374 | 2.16 |
ENST00000442502.2
|
CA10
|
carbonic anhydrase X |
chr5_-_142077569 | 2.16 |
ENST00000407758.1
ENST00000441680.2 ENST00000419524.2 |
FGF1
|
fibroblast growth factor 1 (acidic) |
chr12_-_62586543 | 2.15 |
ENST00000416284.3
|
FAM19A2
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A2 |
chr5_+_36608422 | 2.14 |
ENST00000381918.3
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
chr16_+_58533951 | 2.14 |
ENST00000566192.1
ENST00000565088.1 ENST00000568640.1 ENST00000563978.1 ENST00000569923.1 ENST00000356752.4 ENST00000563799.1 ENST00000562999.1 ENST00000570248.1 ENST00000562731.1 ENST00000568424.1 |
NDRG4
|
NDRG family member 4 |
chr14_+_62462541 | 2.12 |
ENST00000430451.2
|
SYT16
|
synaptotagmin XVI |
chrX_-_13956737 | 2.10 |
ENST00000454189.2
|
GPM6B
|
glycoprotein M6B |
chr8_-_57359131 | 2.10 |
ENST00000518974.1
ENST00000523051.1 ENST00000518770.1 ENST00000451791.2 |
PENK
|
proenkephalin |
chr13_-_45775162 | 2.09 |
ENST00000405872.1
|
KCTD4
|
potassium channel tetramerization domain containing 4 |
chr5_+_143584814 | 2.07 |
ENST00000507359.3
|
KCTD16
|
potassium channel tetramerization domain containing 16 |
chr20_-_43729750 | 2.06 |
ENST00000537075.1
ENST00000306117.1 |
KCNS1
|
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1 |
chr17_-_29624343 | 2.06 |
ENST00000247271.4
|
OMG
|
oligodendrocyte myelin glycoprotein |
chr19_-_51466681 | 2.05 |
ENST00000456750.2
|
KLK6
|
kallikrein-related peptidase 6 |
chr11_-_125366089 | 2.03 |
ENST00000366139.3
ENST00000278919.3 |
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I) |
chr8_-_57358432 | 2.02 |
ENST00000517415.1
ENST00000314922.3 |
PENK
|
proenkephalin |
chr2_+_162480967 | 2.01 |
ENST00000421911.1
|
SLC4A10
|
solute carrier family 4, sodium bicarbonate transporter, member 10 |
chr12_+_129028500 | 2.01 |
ENST00000315208.8
|
TMEM132C
|
transmembrane protein 132C |
chr1_+_202995611 | 2.01 |
ENST00000367240.2
|
PPFIA4
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 |
chr2_+_162480918 | 2.00 |
ENST00000272716.5
ENST00000446997.1 |
SLC4A10
|
solute carrier family 4, sodium bicarbonate transporter, member 10 |
chr11_-_88796803 | 2.00 |
ENST00000418177.2
ENST00000455756.2 |
GRM5
|
glutamate receptor, metabotropic 5 |
chr18_-_31802056 | 2.00 |
ENST00000538587.1
|
NOL4
|
nucleolar protein 4 |
chrX_-_151619746 | 1.99 |
ENST00000370314.4
|
GABRA3
|
gamma-aminobutyric acid (GABA) A receptor, alpha 3 |
chr13_-_25754077 | 1.99 |
ENST00000413501.1
|
AMER2-AS1
|
AMER2 antisense RNA 1 (head to head) |
chr5_+_137774706 | 1.99 |
ENST00000378339.2
ENST00000254901.5 ENST00000506158.1 |
REEP2
|
receptor accessory protein 2 |
chr2_-_99485825 | 1.98 |
ENST00000423771.1
|
KIAA1211L
|
KIAA1211-like |
chr2_+_168675182 | 1.97 |
ENST00000305861.1
|
B3GALT1
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
chr4_-_163085107 | 1.97 |
ENST00000379164.4
|
FSTL5
|
follistatin-like 5 |
chr18_-_5577640 | 1.96 |
ENST00000582592.1
|
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3 |
chr9_-_34523027 | 1.94 |
ENST00000399775.2
|
ENHO
|
energy homeostasis associated |
chr5_+_140579162 | 1.94 |
ENST00000536699.1
ENST00000354757.3 |
PCDHB11
|
protocadherin beta 11 |
chr4_-_87279641 | 1.93 |
ENST00000512689.1
|
MAPK10
|
mitogen-activated protein kinase 10 |
chr2_-_175711133 | 1.91 |
ENST00000409597.1
ENST00000413882.1 |
CHN1
|
chimerin 1 |
chr8_+_85097110 | 1.90 |
ENST00000517638.1
ENST00000522647.1 |
RALYL
|
RALY RNA binding protein-like |
chr18_-_31802282 | 1.89 |
ENST00000535475.1
|
NOL4
|
nucleolar protein 4 |
chr3_+_147657764 | 1.89 |
ENST00000467198.1
ENST00000485006.1 |
RP11-71N10.1
|
RP11-71N10.1 |
chr5_+_140557371 | 1.89 |
ENST00000239444.2
|
PCDHB8
|
protocadherin beta 8 |
chrX_-_13835461 | 1.89 |
ENST00000316715.4
ENST00000356942.5 |
GPM6B
|
glycoprotein M6B |
chr17_+_37783170 | 1.89 |
ENST00000254079.4
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
chr8_+_35649365 | 1.88 |
ENST00000437887.1
|
AC012215.1
|
Uncharacterized protein |
chr13_-_96296944 | 1.88 |
ENST00000361396.2
ENST00000376829.2 |
DZIP1
|
DAZ interacting zinc finger protein 1 |
chr9_+_77230499 | 1.88 |
ENST00000396204.2
|
RORB
|
RAR-related orphan receptor B |
chr20_+_5892037 | 1.86 |
ENST00000378961.4
|
CHGB
|
chromogranin B (secretogranin 1) |
chr7_+_87563557 | 1.86 |
ENST00000439864.1
ENST00000412441.1 ENST00000398201.4 ENST00000265727.7 ENST00000315984.7 ENST00000398209.3 |
ADAM22
|
ADAM metallopeptidase domain 22 |
chr3_-_178103144 | 1.86 |
ENST00000417383.1
ENST00000418585.1 ENST00000411727.1 ENST00000439810.1 |
RP11-33A14.1
|
RP11-33A14.1 |
chr1_+_203096831 | 1.84 |
ENST00000337894.4
|
ADORA1
|
adenosine A1 receptor |
chr20_+_20033158 | 1.84 |
ENST00000340348.6
ENST00000377309.2 ENST00000389656.3 ENST00000377306.1 ENST00000245957.5 ENST00000377303.2 ENST00000475466.1 |
C20orf26
|
chromosome 20 open reading frame 26 |
chr18_-_31628558 | 1.84 |
ENST00000535384.1
|
NOL4
|
nucleolar protein 4 |
chr8_-_30891078 | 1.83 |
ENST00000339382.2
ENST00000475541.1 |
PURG
|
purine-rich element binding protein G |
chr19_-_51456321 | 1.82 |
ENST00000391809.2
|
KLK5
|
kallikrein-related peptidase 5 |
chr11_+_124609742 | 1.81 |
ENST00000284292.6
|
NRGN
|
neurogranin (protein kinase C substrate, RC3) |
chr19_+_55795493 | 1.80 |
ENST00000309383.1
|
BRSK1
|
BR serine/threonine kinase 1 |
chr7_+_24323782 | 1.80 |
ENST00000242152.2
ENST00000407573.1 |
NPY
|
neuropeptide Y |
chr7_-_107968921 | 1.80 |
ENST00000442580.1
|
NRCAM
|
neuronal cell adhesion molecule |
chr5_+_143550396 | 1.79 |
ENST00000512467.1
|
KCTD16
|
potassium channel tetramerization domain containing 16 |
chr19_-_51456344 | 1.79 |
ENST00000336334.3
ENST00000593428.1 |
KLK5
|
kallikrein-related peptidase 5 |
chr4_+_159131346 | 1.78 |
ENST00000508243.1
ENST00000296529.6 |
TMEM144
|
transmembrane protein 144 |
chr7_+_142636603 | 1.77 |
ENST00000409607.3
|
C7orf34
|
chromosome 7 open reading frame 34 |
chr10_+_18240834 | 1.77 |
ENST00000377371.3
ENST00000539911.1 |
SLC39A12
|
solute carrier family 39 (zinc transporter), member 12 |
chr7_+_142636440 | 1.76 |
ENST00000458732.1
|
C7orf34
|
chromosome 7 open reading frame 34 |
chrX_+_65382433 | 1.76 |
ENST00000374727.3
|
HEPH
|
hephaestin |
chr4_-_87278857 | 1.75 |
ENST00000509464.1
ENST00000511167.1 |
MAPK10
|
mitogen-activated protein kinase 10 |
chr1_-_177133818 | 1.74 |
ENST00000424564.2
ENST00000361833.2 |
ASTN1
|
astrotactin 1 |
chr10_+_106918686 | 1.74 |
ENST00000393176.2
|
SORCS3
|
sortilin-related VPS10 domain containing receptor 3 |
chr1_+_86934526 | 1.74 |
ENST00000394711.1
|
CLCA1
|
chloride channel accessory 1 |
chr4_-_87279520 | 1.74 |
ENST00000506773.1
|
MAPK10
|
mitogen-activated protein kinase 10 |
chr16_-_62070305 | 1.74 |
ENST00000584337.1
|
CDH8
|
cadherin 8, type 2 |
chr14_+_24540154 | 1.73 |
ENST00000559778.1
ENST00000560761.1 ENST00000557889.1 |
CPNE6
|
copine VI (neuronal) |
chr5_+_140535577 | 1.72 |
ENST00000539533.1
|
PCDHB17
|
Protocadherin-psi1; Uncharacterized protein |
chr5_-_19988288 | 1.71 |
ENST00000502796.1
ENST00000511273.1 |
CDH18
|
cadherin 18, type 2 |
chr4_+_113970772 | 1.69 |
ENST00000504454.1
ENST00000394537.3 ENST00000357077.4 ENST00000264366.6 |
ANK2
|
ankyrin 2, neuronal |
chr20_+_9494987 | 1.69 |
ENST00000427562.2
ENST00000246070.2 |
LAMP5
|
lysosomal-associated membrane protein family, member 5 |
chr2_+_131769256 | 1.69 |
ENST00000355771.3
|
ARHGEF4
|
Rho guanine nucleotide exchange factor (GEF) 4 |
chr5_-_19988339 | 1.68 |
ENST00000382275.1
|
CDH18
|
cadherin 18, type 2 |
chrX_-_13835147 | 1.68 |
ENST00000493677.1
ENST00000355135.2 |
GPM6B
|
glycoprotein M6B |
chr2_+_166430619 | 1.67 |
ENST00000409420.1
|
CSRNP3
|
cysteine-serine-rich nuclear protein 3 |
chr1_-_182369751 | 1.66 |
ENST00000367565.1
|
TEDDM1
|
transmembrane epididymal protein 1 |
chr5_-_35938674 | 1.64 |
ENST00000397366.1
ENST00000513623.1 ENST00000514524.1 ENST00000397367.2 |
CAPSL
|
calcyphosine-like |
chr11_-_88799113 | 1.64 |
ENST00000393294.3
|
GRM5
|
glutamate receptor, metabotropic 5 |
chr19_-_42927251 | 1.64 |
ENST00000597001.1
|
LIPE
|
lipase, hormone-sensitive |
chr18_-_4455260 | 1.64 |
ENST00000581527.1
|
DLGAP1
|
discs, large (Drosophila) homolog-associated protein 1 |
chr1_-_151688528 | 1.64 |
ENST00000290585.4
|
CELF3
|
CUGBP, Elav-like family member 3 |
chr11_+_98891797 | 1.64 |
ENST00000527185.1
ENST00000528682.1 ENST00000524871.1 |
CNTN5
|
contactin 5 |
chr3_-_42744312 | 1.64 |
ENST00000416756.1
ENST00000441594.1 |
HHATL
|
hedgehog acyltransferase-like |
chr1_+_209757051 | 1.64 |
ENST00000009105.1
ENST00000423146.1 ENST00000361322.2 |
CAMK1G
|
calcium/calmodulin-dependent protein kinase IG |
chrX_-_43832711 | 1.63 |
ENST00000378062.5
|
NDP
|
Norrie disease (pseudoglioma) |
chr7_-_107968999 | 1.63 |
ENST00000456431.1
|
NRCAM
|
neuronal cell adhesion molecule |
chr13_-_47471155 | 1.62 |
ENST00000543956.1
ENST00000542664.1 |
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
chr9_-_28670283 | 1.62 |
ENST00000379992.2
|
LINGO2
|
leucine rich repeat and Ig domain containing 2 |
chr3_+_6902794 | 1.62 |
ENST00000357716.4
ENST00000486284.1 ENST00000389336.4 ENST00000403881.1 ENST00000402647.2 |
GRM7
|
glutamate receptor, metabotropic 7 |
chr3_-_42744130 | 1.61 |
ENST00000417472.1
ENST00000442469.1 |
HHATL
|
hedgehog acyltransferase-like |
chr5_+_140220769 | 1.60 |
ENST00000531613.1
ENST00000378123.3 |
PCDHA8
|
protocadherin alpha 8 |
chr1_+_171810606 | 1.60 |
ENST00000358155.4
ENST00000367733.2 ENST00000355305.5 ENST00000367731.1 |
DNM3
|
dynamin 3 |
chr4_-_90757364 | 1.59 |
ENST00000508895.1
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr19_-_38720294 | 1.59 |
ENST00000412732.1
ENST00000456296.1 |
DPF1
|
D4, zinc and double PHD fingers family 1 |
chr11_-_111781554 | 1.58 |
ENST00000526167.1
ENST00000528961.1 |
CRYAB
|
crystallin, alpha B |
chr3_-_42744270 | 1.58 |
ENST00000457462.1
|
HHATL
|
hedgehog acyltransferase-like |
chr12_+_7023491 | 1.57 |
ENST00000541477.1
ENST00000229277.1 |
ENO2
|
enolase 2 (gamma, neuronal) |
chr1_-_111150048 | 1.57 |
ENST00000485317.1
|
KCNA2
|
potassium voltage-gated channel, shaker-related subfamily, member 2 |
chrX_-_99665262 | 1.56 |
ENST00000373034.4
ENST00000255531.7 |
PCDH19
|
protocadherin 19 |
chr19_-_17799008 | 1.56 |
ENST00000519716.2
|
UNC13A
|
unc-13 homolog A (C. elegans) |
chr16_-_29910853 | 1.56 |
ENST00000308713.5
|
SEZ6L2
|
seizure related 6 homolog (mouse)-like 2 |
chr10_+_80027105 | 1.55 |
ENST00000461034.1
ENST00000476909.1 ENST00000459633.1 |
LINC00595
|
long intergenic non-protein coding RNA 595 |
chr7_-_130066571 | 1.55 |
ENST00000492389.1
|
CEP41
|
centrosomal protein 41kDa |
chr17_-_49825148 | 1.55 |
ENST00000575097.1
|
CA10
|
carbonic anhydrase X |
chr15_+_34260921 | 1.53 |
ENST00000560035.1
|
CHRM5
|
cholinergic receptor, muscarinic 5 |
chr20_-_9819479 | 1.53 |
ENST00000378423.1
ENST00000353224.5 |
PAK7
|
p21 protein (Cdc42/Rac)-activated kinase 7 |
chr13_+_53602894 | 1.52 |
ENST00000219022.2
|
OLFM4
|
olfactomedin 4 |
chr7_+_43152191 | 1.52 |
ENST00000395891.2
|
HECW1
|
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 |
chr6_+_72926145 | 1.51 |
ENST00000425662.2
ENST00000453976.2 |
RIMS1
|
regulating synaptic membrane exocytosis 1 |
chr5_+_57878859 | 1.50 |
ENST00000282878.4
|
RAB3C
|
RAB3C, member RAS oncogene family |
chr12_-_71182695 | 1.50 |
ENST00000342084.4
|
PTPRR
|
protein tyrosine phosphatase, receptor type, R |
chr4_-_90758118 | 1.49 |
ENST00000420646.2
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr2_+_162480901 | 1.49 |
ENST00000535165.1
|
SLC4A10
|
solute carrier family 4, sodium bicarbonate transporter, member 10 |
chrX_+_150884500 | 1.48 |
ENST00000370350.3
|
FATE1
|
fetal and adult testis expressed 1 |
chr1_+_230883128 | 1.48 |
ENST00000271971.2
ENST00000354537.1 |
CAPN9
|
calpain 9 |
chr7_-_22234381 | 1.48 |
ENST00000458533.1
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
chr19_-_51054299 | 1.48 |
ENST00000599957.1
|
LRRC4B
|
leucine rich repeat containing 4B |
chr18_-_5396271 | 1.47 |
ENST00000579951.1
|
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3 |
chr10_-_128359008 | 1.47 |
ENST00000488181.1
|
C10orf90
|
chromosome 10 open reading frame 90 |
chr4_-_20985632 | 1.47 |
ENST00000359001.5
|
KCNIP4
|
Kv channel interacting protein 4 |
chr12_+_79258547 | 1.47 |
ENST00000457153.2
|
SYT1
|
synaptotagmin I |
chr8_+_67405755 | 1.47 |
ENST00000521495.1
|
C8orf46
|
chromosome 8 open reading frame 46 |
chr9_-_21305312 | 1.46 |
ENST00000259555.4
|
IFNA5
|
interferon, alpha 5 |
chr10_-_128359074 | 1.46 |
ENST00000544758.1
|
C10orf90
|
chromosome 10 open reading frame 90 |
chr18_+_52385068 | 1.45 |
ENST00000586570.1
|
RAB27B
|
RAB27B, member RAS oncogene family |
chr6_+_72922590 | 1.45 |
ENST00000523963.1
|
RIMS1
|
regulating synaptic membrane exocytosis 1 |
chr20_-_54580523 | 1.44 |
ENST00000064571.2
|
CBLN4
|
cerebellin 4 precursor |
chr16_-_29910365 | 1.43 |
ENST00000346932.5
ENST00000350527.3 ENST00000537485.1 ENST00000568380.1 |
SEZ6L2
|
seizure related 6 homolog (mouse)-like 2 |
chr10_+_64133934 | 1.42 |
ENST00000395254.3
ENST00000395255.3 ENST00000410046.3 |
ZNF365
|
zinc finger protein 365 |
chr22_+_27727733 | 1.42 |
ENST00000413244.1
|
CTA-929C8.8
|
CTA-929C8.8 |
chr6_+_72922505 | 1.42 |
ENST00000401910.3
|
RIMS1
|
regulating synaptic membrane exocytosis 1 |
chr5_+_140772381 | 1.41 |
ENST00000398604.2
|
PCDHGA8
|
protocadherin gamma subfamily A, 8 |
chr11_-_35440579 | 1.41 |
ENST00000606205.1
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr4_+_89300158 | 1.41 |
ENST00000502870.1
|
HERC6
|
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 |
chr5_-_88180342 | 1.39 |
ENST00000502983.1
|
MEF2C
|
myocyte enhancer factor 2C |
chr2_+_162480845 | 1.39 |
ENST00000375514.5
ENST00000415876.2 |
SLC4A10
|
solute carrier family 4, sodium bicarbonate transporter, member 10 |
chr10_+_60936921 | 1.39 |
ENST00000373878.3
|
PHYHIPL
|
phytanoyl-CoA 2-hydroxylase interacting protein-like |
chr1_+_44889697 | 1.38 |
ENST00000443020.2
|
RNF220
|
ring finger protein 220 |
chr5_-_93077293 | 1.37 |
ENST00000510627.4
|
POU5F2
|
POU domain class 5, transcription factor 2 |
chr5_+_38148582 | 1.37 |
ENST00000508853.1
|
CTD-2207A17.1
|
CTD-2207A17.1 |
chr12_+_32638897 | 1.37 |
ENST00000531134.1
|
FGD4
|
FYVE, RhoGEF and PH domain containing 4 |
chr7_-_123673471 | 1.37 |
ENST00000455783.1
|
TMEM229A
|
transmembrane protein 229A |
chr5_+_36608280 | 1.36 |
ENST00000513646.1
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
chr18_+_32173276 | 1.35 |
ENST00000591816.1
ENST00000588125.1 ENST00000598334.1 ENST00000588684.1 ENST00000554864.3 ENST00000399121.5 ENST00000595022.1 ENST00000269190.7 ENST00000399097.3 |
DTNA
|
dystrobrevin, alpha |
chr9_-_79307096 | 1.35 |
ENST00000376717.2
ENST00000223609.6 ENST00000443509.2 |
PRUNE2
|
prune homolog 2 (Drosophila) |
chr12_-_57410304 | 1.34 |
ENST00000441881.1
ENST00000458521.2 |
TAC3
|
tachykinin 3 |
chr6_+_146348782 | 1.34 |
ENST00000361719.2
ENST00000392299.2 |
GRM1
|
glutamate receptor, metabotropic 1 |
chr5_+_71403061 | 1.33 |
ENST00000512974.1
ENST00000296755.7 |
MAP1B
|
microtubule-associated protein 1B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.7 | GO:1903280 | negative regulation of calcium:sodium antiporter activity(GO:1903280) |
1.6 | 9.7 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
1.4 | 4.1 | GO:0040040 | thermosensory behavior(GO:0040040) |
1.2 | 4.8 | GO:0060254 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
1.1 | 3.3 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
0.9 | 3.6 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.8 | 4.1 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.8 | 8.8 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.8 | 2.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.7 | 4.2 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.7 | 7.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.6 | 3.8 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.6 | 1.8 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
0.6 | 4.9 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.6 | 7.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.5 | 1.6 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.5 | 1.5 | GO:0060304 | regulation of phosphatidylinositol dephosphorylation(GO:0060304) |
0.4 | 7.1 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.4 | 3.1 | GO:0003185 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.4 | 1.2 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.4 | 1.2 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
0.4 | 0.8 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.4 | 1.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.4 | 1.8 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.3 | 2.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.3 | 1.4 | GO:1904647 | response to rotenone(GO:1904647) |
0.3 | 1.7 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
0.3 | 8.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 4.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.3 | 1.6 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.3 | 1.6 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.3 | 7.1 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.3 | 1.0 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.3 | 1.3 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.3 | 1.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 0.9 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.3 | 0.9 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.3 | 1.7 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.3 | 0.8 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.3 | 2.2 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.3 | 6.4 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.3 | 0.8 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
0.3 | 1.6 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 2.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 1.6 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.3 | 1.3 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.3 | 0.5 | GO:1903524 | positive regulation of blood circulation(GO:1903524) |
0.3 | 1.6 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.3 | 2.3 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.3 | 1.0 | GO:0090260 | negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
0.3 | 1.3 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.3 | 2.5 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.3 | 1.0 | GO:1903487 | regulation of lactation(GO:1903487) |
0.3 | 1.0 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.2 | 2.5 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.2 | 0.7 | GO:0002588 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.2 | 1.4 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.2 | 1.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.2 | 0.9 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 1.5 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.2 | 1.9 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.2 | 1.1 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.2 | 0.6 | GO:0099612 | protein localization to axon(GO:0099612) |
0.2 | 0.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 1.7 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 3.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 7.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 2.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.6 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 1.0 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.2 | 3.0 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.2 | 2.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 1.9 | GO:0097338 | response to clozapine(GO:0097338) |
0.2 | 1.9 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.2 | 0.6 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
0.2 | 4.8 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.2 | 1.6 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.2 | 1.8 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.2 | 2.0 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.2 | 4.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.5 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.2 | 1.1 | GO:2000329 | negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
0.2 | 0.5 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.2 | 0.7 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.2 | 1.0 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.2 | 1.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.6 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.2 | 0.6 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.2 | 1.9 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 2.2 | GO:0035768 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
0.2 | 0.5 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.2 | 4.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 1.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 1.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 1.5 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.2 | 2.4 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 1.0 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.1 | 0.9 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.9 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.1 | 0.4 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.1 | 0.4 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.1 | 0.4 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.1 | 0.7 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.4 | GO:0021589 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.1 | 3.1 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 1.2 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.1 | 2.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.7 | GO:2000691 | regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.1 | 0.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.9 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.9 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 3.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.8 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.1 | 0.8 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.1 | 1.0 | GO:0015811 | L-cystine transport(GO:0015811) |
0.1 | 7.4 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 1.2 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.1 | 5.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.6 | GO:0048867 | ganglion mother cell fate determination(GO:0007402) stem cell fate determination(GO:0048867) |
0.1 | 0.3 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.1 | 0.8 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.1 | 1.6 | GO:0046661 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) male sex differentiation(GO:0046661) |
0.1 | 0.7 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
0.1 | 1.0 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.1 | 0.3 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.7 | GO:1900827 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.1 | 4.0 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 2.5 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 7.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.3 | GO:0042245 | RNA repair(GO:0042245) |
0.1 | 0.9 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.1 | 2.1 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 0.8 | GO:1902996 | regulation of neuronal signal transduction(GO:1902847) regulation of neurofibrillary tangle assembly(GO:1902996) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.1 | 1.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 1.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.4 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 2.2 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 1.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 2.1 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 0.5 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 1.2 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.1 | 0.4 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.1 | 0.3 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.1 | 2.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 1.2 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 1.7 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.1 | 1.6 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 1.1 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.1 | 2.9 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 16.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.7 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.1 | 4.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.3 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.9 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 1.6 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 4.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.2 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.1 | 0.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 2.5 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 2.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.3 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
0.1 | 1.0 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.1 | 0.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 1.4 | GO:0075713 | establishment of integrated proviral latency(GO:0075713) |
0.1 | 1.4 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.3 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
0.1 | 0.3 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.1 | 1.6 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 4.3 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.5 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.1 | 1.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.1 | 1.3 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.1 | 1.0 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 1.1 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 0.6 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.1 | 0.3 | GO:2000671 | cellular response to sorbitol(GO:0072709) regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.8 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.1 | 1.1 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.3 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.1 | 0.2 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
0.1 | 0.5 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.1 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.8 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.7 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.4 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 0.1 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.1 | 0.2 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
0.1 | 0.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.6 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 1.0 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.1 | 4.7 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.1 | 1.0 | GO:1903209 | positive regulation of oxidative stress-induced cell death(GO:1903209) |
0.1 | 2.0 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.6 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.7 | GO:0001893 | maternal placenta development(GO:0001893) |
0.1 | 6.1 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.6 | GO:0090179 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.1 | 0.7 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.8 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 0.2 | GO:1903823 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
0.1 | 0.4 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 1.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.6 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.4 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.8 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 1.9 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 0.4 | GO:0045345 | positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.0 | 1.6 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 1.9 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.2 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 3.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.6 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.6 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.2 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
0.0 | 1.0 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 1.2 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 11.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 2.6 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 1.2 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.3 | GO:0046373 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
0.0 | 1.1 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.6 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.3 | GO:0035900 | isocitrate metabolic process(GO:0006102) response to isolation stress(GO:0035900) |
0.0 | 0.5 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.8 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.7 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.0 | 8.6 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.0 | 0.3 | GO:0030239 | myofibril assembly(GO:0030239) |
0.0 | 0.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.5 | GO:0032264 | IMP salvage(GO:0032264) |
0.0 | 0.3 | GO:0015698 | inorganic anion transport(GO:0015698) |
0.0 | 3.4 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.0 | 0.8 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.2 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.0 | 0.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 1.2 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.0 | 0.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 1.8 | GO:0031113 | regulation of microtubule polymerization(GO:0031113) |
0.0 | 0.3 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.0 | 0.7 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.1 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.0 | 0.9 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.4 | GO:0048263 | determination of dorsal identity(GO:0048263) |
0.0 | 0.2 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
0.0 | 0.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.1 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.1 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.0 | 0.5 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.0 | 0.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 0.7 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.0 | 0.2 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.0 | 0.7 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.6 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 0.4 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.2 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.0 | 0.6 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.0 | 0.1 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.0 | 0.3 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.0 | 1.0 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.7 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.0 | 1.2 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.3 | GO:0048858 | cell part morphogenesis(GO:0032990) cell projection morphogenesis(GO:0048858) |
0.0 | 0.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.5 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 3.0 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.0 | 0.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 1.8 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 1.1 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.0 | 0.3 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.5 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.2 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.0 | 0.4 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.0 | 0.7 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 1.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.3 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.0 | 0.3 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.6 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.0 | 0.7 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.6 | GO:0044241 | lipid digestion(GO:0044241) |
0.0 | 0.4 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.4 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 3.8 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.4 | GO:0030828 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 1.4 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.0 | 0.2 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.0 | 1.8 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.9 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.2 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.0 | 0.1 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.0 | 0.4 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.4 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 2.1 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.0 | 0.1 | GO:0001776 | leukocyte homeostasis(GO:0001776) lymphocyte homeostasis(GO:0002260) |
0.0 | 0.4 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.0 | 0.5 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 2.1 | GO:0051298 | centrosome duplication(GO:0051298) |
0.0 | 1.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.1 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.0 | 0.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.1 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.0 | 0.1 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.0 | 0.2 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.0 | 0.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.8 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 2.8 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.6 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.4 | GO:0045859 | regulation of protein kinase activity(GO:0045859) |
0.0 | 0.1 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
0.0 | 0.8 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.1 | GO:0030163 | protein catabolic process(GO:0030163) |
0.0 | 0.3 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.7 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.4 | GO:0051904 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
0.0 | 1.2 | GO:0021762 | substantia nigra development(GO:0021762) |
0.0 | 0.2 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.0 | 0.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.3 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.3 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.5 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.3 | GO:0016573 | histone acetylation(GO:0016573) |
0.0 | 0.0 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.0 | 0.0 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.5 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.1 | GO:0097475 | motor neuron migration(GO:0097475) |
0.0 | 0.5 | GO:0051648 | vesicle localization(GO:0051648) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 2.0 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.0 | 0.2 | GO:0060349 | bone morphogenesis(GO:0060349) |
0.0 | 0.1 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.0 | 0.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.0 | 0.1 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.5 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.0 | 0.2 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 1.0 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.5 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.1 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.0 | 0.1 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.0 | 0.5 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.4 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.2 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.1 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 1.2 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 4.6 | GO:0098916 | chemical synaptic transmission(GO:0007268) anterograde trans-synaptic signaling(GO:0098916) trans-synaptic signaling(GO:0099537) |
0.0 | 0.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.0 | GO:0072578 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) neurotransmitter-gated ion channel clustering(GO:0072578) glycine receptor clustering(GO:0072579) gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.0 | 0.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 6.9 | GO:0097441 | basilar dendrite(GO:0097441) |
1.1 | 9.7 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.7 | 5.7 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.6 | 2.5 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.5 | 3.8 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.5 | 3.2 | GO:0044308 | axonal spine(GO:0044308) |
0.5 | 1.6 | GO:0098844 | postsynaptic endocytic zone membrane(GO:0098844) |
0.5 | 1.5 | GO:0036457 | keratohyalin granule(GO:0036457) |
0.5 | 3.5 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.4 | 4.0 | GO:0071547 | piP-body(GO:0071547) |
0.4 | 1.5 | GO:0033011 | perinuclear theca(GO:0033011) |
0.4 | 0.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.3 | 8.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.3 | 1.7 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.3 | 0.8 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.3 | 4.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 2.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 4.5 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 1.8 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 1.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 12.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 1.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 3.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 2.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 1.0 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.2 | 2.2 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 1.9 | GO:0033010 | paranodal junction(GO:0033010) |
0.2 | 4.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 1.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 4.3 | GO:0043194 | axon initial segment(GO:0043194) |
0.2 | 0.9 | GO:0031673 | H zone(GO:0031673) |
0.2 | 1.4 | GO:0042025 | host cell nucleus(GO:0042025) |
0.1 | 2.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.7 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
0.1 | 0.4 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.1 | 0.4 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.1 | 0.1 | GO:0060187 | cell pole(GO:0060187) |
0.1 | 0.4 | GO:0035838 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
0.1 | 2.1 | GO:0031253 | cell projection membrane(GO:0031253) |
0.1 | 1.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 10.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.4 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
0.1 | 2.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 0.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 12.4 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 2.8 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 2.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 9.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 1.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 1.9 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 2.7 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 9.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 2.3 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.3 | GO:0001534 | radial spoke(GO:0001534) |
0.1 | 1.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 2.9 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.4 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 1.5 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 2.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.6 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 2.0 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 1.8 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.5 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.6 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.7 | GO:0030054 | cell junction(GO:0030054) |
0.1 | 1.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.1 | 1.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 1.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 2.1 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 11.2 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.3 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.1 | 2.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 1.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.2 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.1 | 0.8 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 1.4 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 21.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 6.0 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 1.9 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.5 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 1.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.4 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 5.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 5.7 | GO:0044309 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.0 | 0.6 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.5 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 6.6 | GO:0098794 | postsynapse(GO:0098794) |
0.0 | 4.8 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.3 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.0 | 0.1 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
0.0 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.4 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.0 | 0.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 0.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 2.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 1.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 1.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 1.1 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 1.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 0.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 1.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.9 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 2.7 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.9 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.0 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.4 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.1 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
0.0 | 7.6 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 1.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.4 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.0 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.6 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 0.9 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 10.8 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 2.0 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.4 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 1.0 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 3.7 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 1.0 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.6 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 1.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 5.2 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 0.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.3 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 0.2 | GO:0034518 | RNA cap binding complex(GO:0034518) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 9.7 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.9 | 8.5 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.8 | 3.3 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.7 | 7.3 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.7 | 4.2 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.7 | 7.9 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.7 | 2.0 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.6 | 3.1 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.6 | 4.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.5 | 1.6 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.5 | 1.6 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
0.5 | 6.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.4 | 1.9 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
0.4 | 1.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.4 | 2.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.4 | 8.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.3 | 1.3 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.3 | 2.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.3 | 9.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 3.6 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 3.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 1.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.3 | 1.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 1.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.3 | 1.7 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.3 | 1.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 2.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.3 | 1.6 | GO:0070905 | serine binding(GO:0070905) |
0.3 | 1.0 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.2 | 6.9 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 0.7 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.2 | 0.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 0.7 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
0.2 | 1.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.2 | 1.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.2 | 0.7 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 0.6 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
0.2 | 0.6 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
0.2 | 1.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 1.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 0.6 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.2 | 0.7 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 1.8 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 0.5 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.2 | 2.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 2.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 5.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 1.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.2 | 1.2 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.2 | 0.8 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.1 | 0.9 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.1 | 6.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.4 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.1 | 3.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 1.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 1.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 2.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.7 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 1.0 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.5 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
0.1 | 1.1 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 3.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.9 | GO:0035276 | ethanol binding(GO:0035276) |
0.1 | 4.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 3.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 1.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 4.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 3.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 1.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 2.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.9 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.1 | 0.3 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
0.1 | 0.3 | GO:0090541 | MIT domain binding(GO:0090541) |
0.1 | 0.4 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.6 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 1.4 | GO:0019871 | potassium channel inhibitor activity(GO:0019870) sodium channel inhibitor activity(GO:0019871) |
0.1 | 2.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.3 | GO:0047860 | diiodophenylpyruvate reductase activity(GO:0047860) |
0.1 | 0.3 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.1 | 2.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.6 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 1.8 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 0.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 1.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.2 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.1 | 0.2 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
0.1 | 0.6 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 1.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 1.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 1.0 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 0.3 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.1 | 0.9 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 2.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.3 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 3.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.6 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 4.9 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.4 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.1 | 1.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.7 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.6 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 2.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.7 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.5 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.1 | 0.9 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 2.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 5.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 13.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.7 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.1 | 0.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 2.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 2.8 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 4.6 | GO:1901476 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
0.1 | 2.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.2 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.1 | 1.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 1.0 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 1.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 1.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 2.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 2.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.4 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.6 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.0 | 2.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 1.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 1.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.2 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.4 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.2 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.0 | 10.0 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.5 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 2.4 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
0.0 | 0.3 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
0.0 | 0.1 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.0 | 0.9 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 9.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 1.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 6.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 2.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 1.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.3 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.0 | 1.0 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 1.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 2.1 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 2.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.6 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 1.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 1.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 12.1 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 1.8 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 2.1 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 0.4 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 3.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 1.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 3.2 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.8 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 1.8 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.2 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 1.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 1.9 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 9.3 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 0.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 1.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 1.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 1.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.1 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.0 | 0.2 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.5 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 2.4 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.1 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 1.4 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.4 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.7 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.3 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.0 | 2.0 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 1.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.3 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.6 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 0.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.8 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 1.3 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.2 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 1.2 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.5 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 1.3 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.0 | GO:0061598 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
0.0 | 9.5 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 16.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 7.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 2.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 3.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 2.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 7.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 2.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 4.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 5.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 1.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 4.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 2.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 1.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 4.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 3.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 1.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 3.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 3.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 1.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 1.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 3.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 2.2 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 1.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 1.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 1.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 1.0 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 2.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 1.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.5 | PID AURORA A PATHWAY | Aurora A signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 14.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.3 | 7.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 6.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 4.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 7.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 9.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 2.5 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 4.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 2.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 4.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.8 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 0.4 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.1 | 3.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 7.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 3.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 1.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 4.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.9 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 1.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 4.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 1.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 13.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 2.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 2.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 2.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 7.8 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 10.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 2.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 2.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 1.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 1.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 1.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.0 | 0.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 1.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 2.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 1.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 1.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 1.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 3.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 4.2 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.0 | 1.8 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.4 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.9 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.6 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 3.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.2 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 0.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.2 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.0 | 0.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 1.1 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |